Paper8375129
The influence of dose and ethnic origins on the pharmacokinetics of nifedipine.
Ahsan CH and 5 others. Clin Pharmacol Ther, 1993. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. The influence of dose and ethnic origins on the pharmacokinetics of nifedipine. Papers, record 8375129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8375129
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nifedipine | Major topic |
| White People | Major topic |
| Adult | |
| Bangladesh | |
| Blood Proteins | |
| Female | |
| Half-Life | |
| Hemodynamics | |
| Humans | |
| Male | |
| Middle Aged | |
| Protein Binding | |
| Reference Values |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42296571 | Pharmacogenomics of antibacterial and antiviral therapies: Clinical actionability, evidence gaps, and future directions. | Pharmacol Rev | 2026 | https://conductscience.org/library/papers/42296571 | PubMed |
| 41499374 | Using Physiologically Based Pharmacokinetic Modeling and Simulations to Predict Antihypertensive Drug Doses in Cirrhotic Patients. | J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/41499374 | PubMed |
| 38130031 | Use of physiologically-based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended-release nifedipine. | CPT Pharmacometrics Syst Pharmacol | 2024 | https://conductscience.org/library/papers/38130031 | PubMed |
| 37309079 | Model-based meta-analysis of ethnic differences and their variabilities in clearance of oral drugs classified by clearance mechanism. | CPT Pharmacometrics Syst Pharmacol | 2023 | https://conductscience.org/library/papers/37309079 | PubMed |
| 34273255 | Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome. | CPT Pharmacometrics Syst Pharmacol | 2021 | https://conductscience.org/library/papers/34273255 | PubMed |
| 30629861 | Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects. | Clin Pharmacol Drug Dev | 2019 | https://conductscience.org/library/papers/30629861 | PubMed |
| 30386625 | Pharmacokinetics and safety of Enasidenib following single oral doses in Japanese and Caucasian subjects. | Pharmacol Res Perspect | 2018 | https://conductscience.org/library/papers/30386625 | PubMed |
| 25385446 | Interethnic differences in pharmacokinetics of antibacterials. | Clin Pharmacokinet | 2015 | https://conductscience.org/library/papers/25385446 | PubMed |
| 24869931 | Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA. | Oncologist | 2014 | https://conductscience.org/library/papers/24869931 | PubMed |
| 16984210 | Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics. | Clin Pharmacokinet | 2006 | https://conductscience.org/library/papers/16984210 | PubMed |
| 14531721 | Dietary effects on drug metabolism and transport. | Clin Pharmacokinet | 2003 | https://conductscience.org/library/papers/14531721 | PubMed |
| 11422016 | Population pharmacokinetics of carbamazepine in Singapore epileptic patients. | Br J Clin Pharmacol | 2001 | https://conductscience.org/library/papers/11422016 | PubMed |
| 10319190 | Cytochrome P450 enzymes and drug metabolism--basic concepts and methods of assessment. | Cell Mol Neurobiol | 1999 | https://conductscience.org/library/papers/10319190 | PubMed |
| 9663814 | Inter-ethnic comparisons of the pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin. | Br J Clin Pharmacol | 1998 | https://conductscience.org/library/papers/9663814 | PubMed |
| 9342505 | Clinical pharmacokinetic considerations in the elderly. An update. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9342505 | PubMed |
| 9084960 | Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9084960 | PubMed |
| 9084065 | The pharmacokinetics and pharmacodynamics of adinazolam: multi-ethnic comparisons. | Psychopharmacology (Berl) | 1997 | https://conductscience.org/library/papers/9084065 | PubMed |
| 8703655 | Ethnic differences in nifedipine kinetics: comparisons between Nigerians, Caucasians and South Asians. | Br J Clin Pharmacol | 1995 | https://conductscience.org/library/papers/8703655 | PubMed |
| 8527268 | Factors affecting the absolute bioavailability of nifedipine. | Br J Clin Pharmacol | 1995 | https://conductscience.org/library/papers/8527268 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8375129
GET https://conductscience.org/api/papers/v1/8375129/authors